
==== Front
BMJ Open
BMJ Open
bmjopen
bmjopen
BMJ Open
2044-6055
BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR

39231554
10.1136/bmjopen-2023-080803
bmjopen-2023-080803
Original Research
Neurology
1713
1506
Association between apathy and caregiver burden in patients with amyotrophic lateral sclerosis: a cross-sectional study
http://orcid.org/0000-0001-6105-0587
Gong Zhenxiang 1gongzxhust@163.com

Deng Wenhua 1launsery74@163.com

Li Zehui 1871108925@qq.com

Tang Jiahui 12jhtang1016@163.com

Zhang Min 13zhang_min_3464@126.com

1 Department of Neurology, Huazhong University of Science and Technology Tongji Medical College Tongji Hospital, Wuhan, Hubei, China
2 Department of Neurology, The First Affiliated Hospital of Xiamen University, Xiamen, China
3 Department of Neurology, Shanxi Bethune Hospital, Taiyuan, China
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

None declared.

Dr; zhang_min_3464@126.com
2024
3 9 2024
14 9 e08080312 10 2023
24 8 2024
Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Abstract

Objectives

To investigate the relationship among patients’ apathy, cognitive impairment, depression, anxiety, and caregiver burden in amyotrophic lateral sclerosis (ALS).

Design

A cross-sectional study design was used.

Setting

The study was conducted at a tertiary hospital in Wuhan, Hubei, China.

Participants

A total of 109 patients with ALS and their caregivers were included.

Outcome measures

Patients with ALS were screened using the Edinburgh Cognitive and Behavioural Screen, Beck Depression Inventory-II, Generalised Anxiety Disorder-7 and Apathy Scale to assess their cognition, depression, anxiety and apathy, respectively. The primary caregivers completed the Zarit Burden Interview. The association between apathy, cognitive impairment, depression, anxiety and caregiver burden was analysed using logistic regression. Mediation models were employed to investigate the mediating effect of patients’ apathy on the relationship between depression/anxiety and caregiver burden.

Results

Patients in the high caregiver burden group exhibited significantly higher levels of depression, anxiety and apathy compared with those in the low caregiver burden group (p<0.05). There was a positive association observed between caregiver burden and disease course (rs=0.198, p<0.05), depression (rs=0.189, p<0.05), anxiety (rs=0.257, p<0.05) and apathy (rs=0.388, p<0.05). There was a negative association between caregiver burden and the Revised ALS Functional Rating Scale (rs=−0.275, p<0.05). Apathy was an independent risk factor for higher caregiver burden (OR 1.121, 95% CI 1.041 to 1.206, p<0.05). Apathy fully mediated the relationship between depression and caregiver burden (β=0.35, 95% CI 0.16 to 0.54, p<0.05) while partially mediating the relationship between anxiety and caregiver burden (β=0.34, 95% CI 0.16 to 0.52, p<0.05).

Conclusions

Apathy, depression and anxiety exerted a detrimental impact on caregiver burden in individuals with ALS. Apathy played a mediating role in the relationship between depression and caregiver burden and between anxiety and caregiver burden. These findings underscore the importance of identifying apathy and developing interventions for its management within the context of ALS.

Motor neuron disease
Depression and mood disorders
Caregiver Burden
Cognition
behaviour
http://dx.doi.org/10.13039/100016966 Bethune Charitable Foundation N/A http://dx.doi.org/10.13039/501100001809 National Natural Science Foundation of China 8227052605
==== Body
pmcSTRENGTHS AND LIMITATIONS OF THIS STUDY

The cross-sectional study assessed cognitive function, depression, anxiety, apathy and caregiver burden at the same time.

The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis (ALS) Screen, a recommended ALS-specific cognitive and behavioural scale was used in the study.

A mediation model was used to explore the mediating effect of patients’ apathy between depression, anxiety and caregiver burden.

The study was conducted in a specific hospital in Hubei Province, China, which limits the generalisability of the findings to other populations.

The study lacks detailed information about the caregivers’ medical history, education and work.

Introduction

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by progressive degeneration of upper and lower motor neurons.1 Patients with ALS usually experience a complete loss of motor function within 3–5 years, necessitating the use of gastrostomy and non-invasive ventilation in advanced stages.2 3 Over the past decade, it has been widely recognised that cognitive impairments are present in up to 50% of ALS patients, with 5%–15% meeting diagnostic criteria for frontotemporal dementia (FTD).4 The predisposition to behavioural and psychological symptoms, coupled with declining motor abilities, imposes a substantial physical and mental burden on caregivers, thereby rendering caregiving an arduous task that significantly undermines their well-being.57 A comprehensive understanding of factors associated with high caregiver burden is imperative for developing interventions to support caregivers and improve patients’ quality of life.

In previous studies, depression, anxiety and cognitive and behavioural impairments have been shown to increase caregiver burden. However, high-quality evidence has only been found for overall behavioural impairments.810 In ALS patients, behavioural symptoms include behavioural disinhibition, apathy, loss of sympathy, stereotyped behaviour and altered eating behaviour. Among these symptoms, apathy has the highest prevalence.10 Apathy is conceptualised as a multidimensional syndrome, including cognitive, behavioural, emotional and social dimensions.11 In ALS-frontotemporal spectrum disorder, the most prominent aspect of apathy is its behavioural dimension characterised by reduced motivation for goal-directed behaviour.1214 Consequently, this lack of motivation may lead to non-adherence to recommended treatments among patients and hinder emotional responses to their caregivers,15 16 thereby significantly increasing caregiver burden. The revised diagnostic criteria for ALS with behavioural impairment emphasise apathy as a core feature, highlighting its importance in clinical research and customised interventions.4

Previous studies evaluating the impact of apathy on caregiver burden have overlooked the potential confounding effects and interactions among patients’ cognitive impairments, emotional disorders and apathy.8 17 Notably, previous research has reported significant differences in depression and anxiety levels between patients with and without apathy.18 In ALS patients, cognitive impairments can manifest as executive difficulties and non-executive cognitive dysfunction (such as language deficits, memory impairment and certain psychiatric changes).4 Traditional assessment tools like the Mini-Mental State Examination and the Montreal Cognitive Assessment lack sensitivity in identifying cognitive impairments specific to ALS patients due to their susceptibility to physical dysfunction.19 20 To address this limitation, the Edinburgh Cognitive and Behavioural ALS Screen (ECAS), a concise scale designed specifically for evaluating cognitive and behavioural impairments in ALS patients, has been extensively validated for reliability and validity across various regions.42125 However, despite its utility in other areas of research related to ALS, no prior studies have used the ECAS to investigate caregiver burden or apathy.26 Furthermore, existing literature predominantly focuses on Caucasian populations, while there is a dearth of research involving Chinese populations; thus highlighting potential disparities that may arise from cultural differences between Eastern and Western societies.

This cross-sectional study aimed to investigate the relationship between patients’ apathy, cognitive impairment, depression, anxiety and caregiver burden in patients with ALS. A comprehensive understanding of the factors influencing caregiver burden can provide valuable professional guidance to caregivers and facilitate the development of interventions in clinical practice.

Methods

Study participants

This is a single-centre cross-sectional study conducted between May 2019 and December 2021 at the Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Patients diagnosed with probable or definite ALS based on the revised El Escorial Criteria27 were recruited. Simultaneously, the primary caregiver of each ALS patient was included. The primary caregiver referred to someone who provided continuous healthcare outside the hospital, usually the patient’s spouse or children.28 29 No paid caregivers or healthcare professionals were involved in this research. Patients with ALS combined with frontotemporal lobe dementia (ALS-FTD) were excluded. Patients with comorbid neurological disorders, such as cerebrovascular disease, Alzheimer’s disease, Parkinson’s disease and schizophrenia, were also excluded from the study. Those experiencing severe breathing difficulties and dysarthria (defined as forced vital capacity (%) ≤70% or any bulbar subitem in the revised ALS Functional Rating Scale (ALSFRS-R) ≤2 points) were excluded. Furthermore, ALS patients with comorbid systemic diseases that may potentially cause cognitive impairment, including diabetes mellitus, alcoholic cirrhosis of the liver, chronic obstructive pulmonary disease and renal failure, were also excluded. The study initially recruited 131 patients with ALS and 131 matched caregivers, ultimately only 109 ALS patients and their caregivers were included in the final study, while 22 patients with ALS were excluded for specific reasons (online supplemental figure 1). The sample size was determined based on the Events Per Variable (EPV) criterion: at least 10 EPV in the logistic regression analysis.30

Data acquisition

Two well-trained neurologists performed the physical examinations, motor function assessments and neuropsychological evaluations.

Motor function evaluation and disease staging

The ALSFRS-R was employed for the evaluation of the motor function of patients with ALS.31 The ALSFRS-R consists of 12 items encompassing four subdomains of motor function; each item is rated on a scale from 0 (no function) to 4 (normal function), resulting in a total score ranging from 0 to 48. Higher scores indicate better motor function. The disease progression rate was calculated using the formula: (48-ALSFRS-R)/disease duration (months). Additionally, based on King’s staging system, patients were categorised into stages ranging from stage 1 (symptom onset) to stage 4 (gastrostomy and non-invasive ventilation).32

Cognitive function assessment

The ECAS is a specialised screening tool designed for the identification of cognitive impairments in patients with ALS.33 The ECAS evaluates three ALS-specific cognitive domains (language, verbal fluency and executive function) and two ALS-non-specific cognitive domains (memory and visuospatial function). Additionally, the ECAS includes a concise caregiver-administered questionnaire to evaluate behavioural and psychological abnormalities in patients. For this study, the Chinese version of the ECAS was used, with a total cut-off value of 81.92.23

Depression, anxiety and apathy evaluation

Depression was assessed using the Beck Depression Inventory-II (BDI-II), a 21-item depression self-rating scale with each item ranging from 0 (no symptoms) to 3 (severe symptoms).34 The BDI-II was a revised version of the original BDI as per the Diagnostic and Statistical Manual of Mental Disorder-IV. It has gained widespread recognition as one of the most widely used instruments for measuring depressive symptoms globally. A clinical cut-off value of 10 is recommended for interpreting BDI-II scores, with higher scores indicating the severity of depression.35 36

Anxiety symptoms were measured using the Generalised Anxiety Disorder-7 (GAD-7) questionnaire.37 The GAD-7 comprises seven items; each item is rated on a scale ranging from 0 (not at all) to 3 (nearly every day). Higher scores indicate more severe anxiety symptoms. The GAD-7 questionnaire has been validated in diverse populations and serves as a user-friendly tool for clinicians. A cut-off score of 10 on the GAD-7 is considered indicative of elevated anxiety symptoms.38 39

The Apathy Scale (AS), consisting of 14 items ranging from 0 to 42, was employed to assess apathy levels, with higher scores indicating more severe symptoms. The AS was adapted from the original Apathy Evaluation Scale (AES) developed by Robert Marin.40 Compared with the AES, the AS is briefer and easier to administer, while maintaining a wide range of scores to identify potential apathy. Previous studies have confirmed the reliability and validity of the AS scale in patients with neurodegenerative diseases.41 42 Clinically significant apathy is defined as a score above 14 based on prior research findings.42

Caregiver burden

The burden on primary caregivers was assessed using the Zarit Burden Interview (ZBI) during the patient’s hospitalisation. If the accompanying person during hospitalisation was not the patient’s primary caregiver, the assessment was completed 1 week after discharge via telephone. A fully revised version of the ZBI, comprising 22 items rated on a scale from 0 to 4 with a total score ranging from 0 to 88 was employed in this study.43 Higher ZBI scores indicate increased caregiver burden. The ZBI is the most widely used tool for assessing caregiver burden; previous studies have demonstrated excellent reliability and validity of the ZBI.44 Based on a predefined cut-off value for the ZBI, participants were categorised into two subgroups: low burden (ZBI ≤24) and high burden (ZBI >24) groups.45

Statistical analysis

The normality of data was assessed by the Shapiro-Wilk test. Normally distributed continuous variables were presented as mean (SD), and non-normally distributed continuous variables were reported as median (25% quartile, 75% quartile). Categorical variables were described as frequencies and percentages. Comparisons between the two groups were performed using the Student’s t-test, Mann-Whitney U test or χ2 test, according to the data types. The correlation between clinical features and caregiver burden was analysed using Spearman’s analysis. Binary logistic regression was performed to assess factors influencing caregiver burden. A mediation model was used to investigate the potential interactions among cognitive impairment, depression, anxiety and caregiver burden. The data included in the final analyses were complete and free of any missing values. Statistically significant was defined as p<0.05. All statistical analyses were carried out using SPSS software (V.27.0).

Patient and public involvement

All participants provided written informed consent. The involvement of patients or the public in our research’s design, conducting, reporting or dissemination plans was not sought.

Results

No demographic differences between the high and low caregiver burden groups

In this study, 109 patients with ALS were included, with an average age of 55 years and a median disease course of 11 months. Based on the milestones of disease progression, 72.48% of the patients were classified as King’s stage 1–2, indicating a relatively early course of the disease. The low-burden group consisted of 60 patients, while the high-burden group consisted of 49 patients. Height and weight followed a normal distribution, whereas age, disease duration, ALSFRS-R total score and subitem scores were non-normally distributed. There were no significant differences in age, sex, height, weight, disease course, education level, ALSFRS-R score, disease progression rate or King’s stage between the high and low caregiver burden groups (p>0.05) (table 1).

Table 1 Demographic and clinical characteristics

Characteristics	Low burden	High burden	T/ Z/ F value	P value	
(n=60)	(n=49)	
Age, years	57 (49, 64)	54 (48, 63)	−0.692	0.489*	
Female/male, N	21/39	22/27	0.329	0.293‡	
Height, m	1.66 (0.06)	1.65 (0.07)	0.907	0.367†	
Weight, kg	61.99 (9.80)	59.69 (9.53)	1.233	0.220†	
Disease course, months	10 (6, 16)	11 (8, 21)	0.927	0.354*	
Education, N (%)			−1.341	0.178‡	
Primary school and below	16 (26.67%)	19 (38.78%)	–	–	
Senior school and above	44 (73.33%)	30 (61.22%)	–	–	
Bulb onset, N (%)	8 (13.33%)	9 (18.37%)	0.597	0.471‡	
ALSFRS-R	41 (38, 45)	40 (32, 44)	−1.479	0.139*	
 Bulb	12 (10, 12)	11 (10, 12)	−0.871	0.384*	
 Fine motor	10 (7, 11)	9 (7, 11)	−0.520	0.603*	
 Gross motor	9 (7, 12)	9 (5, 11)	−1.711	0.087*	
 Respiration	12 (11, 12)	12 (11, 12)	−0.279	0.780*	
Disease progression rate	0.65 (0.38, 1.00)	0.73 (0.45, 1.27)	0.844	0.399*	
King’s stage			−1.359	0.395‡	
 Stage I	15 (25.00%)	7 (14.58%)	–	–	
 Stage II	31 (51.67%)	26 (54.17%)	–	–	
 Stage III	9 (15.00%)	12 (25.00%)	–	–	
 Stage IV	5 (8.33%)	3 (6.25%)	–	–	
* Mann-Whitney- U- test;Students t-test; Chi-square test.

† Student’s t-test

‡ χ2 test

ALSFRS-RRevised Amyotrophic Lateral Sclerosis Functional Rating Scale

Psychological differences between high and low caregiver burden groups

Depression, anxiety and cognitive function were evaluated using the aforementioned scales. In this study, 44.95% of caregivers experienced high levels of caregiver burden, while 36.70% of ALS patients met the threshold for clinical apathy (table 2). No significant difference in cognition between the groups with high and low caregiver burden, as indicated by both the total ECAS score and subdomain scores. However, the high caregiver burden group exhibited a higher prevalence of depression and anxiety symptoms compared with the low caregiver burden group (p<0.05). The high caregiver burden group demonstrated a significantly higher AS score than their counterparts (p<0.05), indicating a greater level of apathy within this subgroup (table 2).

Table 2 Cognitive and psychological characteristics

Characteristics	Low burden(n=60)	High burden(n=49)	Z value	P value	
Median (25%, 75%)	Meeting threshold (%)	Median (25%, 75%)	Meeting threshold (%)	
ECAS (total)	84.50 (58.25, 98.75)	32 (53.33%)	83.00 (63.50, 94.00)	25 (51.02%)	0.058	0.954*	
ECAS (language)	19.50 (12.00, 23.00)	41 (68.33%)	19.00 (12.00, 22.50)	31 (63.27%)	−0.351	0.726*	
ECAS (verbal fluency)	16.00 (8.00, 20.00)	42 (70.00%)	16.00 (12.00, 20.00)	39 (79.59%)	0.762	0.446*	
ECAS (executive function)	24.50 (17.25, 32.00)	29 (48.33%)	23.00 (16.00, 30.50)	21 (42.86%)	−0.695	0.487*	
ECAS (memory)	12.50 (3.25, 15.00)	42 (70.00%)	13.00 (7.00, 16.00)	35 (71.43%)	 0.832	0.405*	
EACS (visuospatial function)	11.50 (10.00, 12.00)	30 (50.00%)	12.00 (9.00, 12.00)	30 (61.22%)	0.559	0.576*	
ECAS (ALS-specific)	60.50 (44.00, 73.00)	32 (53.33%)	58.00 (42.50, 69.50)	24 (48.98%)	−0.082	0.934*	
ECAS (ALS-non-specific)	24.00 (12.25, 26.00)	38 (63.33%)	23.00 (17.00, 28.00)	34 (69.39%)	0.602	0.547*	
BDI-II (depression)	10 (4, 15)	27 (45.00%)	11 (8, 22)	27 (55.10%)	2.473	0.013 *	
GAD-7 (anxiety)	2 (0, 5)	4 (6.67%)	5 (1, 11)	12 (24.49%)	2.993	0.003 *	
AS (apathy)	10 (6, 15)	15 (25.00%)	15 (11, 21)	25 (51.02%)	3.837	<0.001 *	
* Mann-Whitney- U- test.

ALSamyotrophic lateral sclerosisASApathy ScaleBDI-IIBeck Depression Inventory-IIECASEdinburgh Cognitive and Behavioural ALS ScreenGAD-7Generalized Anxiety Disorder-7

Clinical and psychological factors correlating with caregiver burden

A correlation analysis was performed to explore the factors influencing caregiver burden. Caregiver burden showed positive association with disease course (rs=0.198, p<0.05), depression (rs=0.189, p<0.05), anxiety (rs=0.257, p<0.05) and apathy (rs=0.388, p<0.05). Caregiver burden exhibited a negative association with ALSFRS-R scores (rs=−0.275, p<0.05). After applying the Bonferroni correction, significant correlations between caregiver burden and ALSFRS-R, anxiety and apathy remained evident (p<0.05/7). No correlation was found between patients’ age or cognitive function and caregiver burden (table 3). Furthermore, binary logistic regression was employed to investigate the impact of cognitive function, depression, anxiety and apathy on caregiver burden perception by caregivers themselves. In the regression model, each one-point increase in the AS score of ALS patients was associated with an 11.7% increase in the likelihood that caregivers perceived the burden to be high (OR 1.121, 95% CI 1.041 to 1.206, p<0.05). In contrast, patients’ depression, anxiety and cognitive function did not affect caregiver burden in the regression model (online supplemental table 1 and figure 1).

Table 3 The relationship between clinical features and caregiver burden

Clinical features	Rs	P value	
Age	0.071	0.464	
Disease course	0.198	0.039	
ALSFRS-R	−0.275	0.004*	
ECAS (cognition)	0.012	0.901	
BDI-II (depression)	0.189	0.049	
GAD-7 (anxiety)	0.257	0.007*	
AS (Apathy)	0.388	<0.001*	
ALSFRS-R, anxiety and apathy were significantly correlated with caregiver burden after Bonferroni correction (*, p value <0.05/7).

ALSFRS-RRevised Amyotrophic Lateral Sclerosis Functional Rating ScaleASApathy ScaleBDI-IIBeck Depression Inventory-IIECASEdinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis ScreenGAD-7Generalised Anxiety Disorder-7

Figure 1 Patients’ apathy is a risk factor for caregiver burden. ALSFRS-R, Revised Amyotrophic Lateral Sclerosis Functional Rating Scale; AS, Apathy Scale; BDI-II, Beck Depression Inventory-II; ECAS, Edinburgh Cognitive and Behavioural Screen; GAD-7, Generalised Anxiety Disorder-7.

Apathy mediates the association between emotional disorders and caregiver burden

The inconsistent results between the correlation analysis and regression model drove us to investigate the interaction among depression, anxiety, cognitive function, apathy and caregiver burden. Apathy, depression and caregiver burden were validated by pairwise correlations (p<0.05) using simple linear regression (online supplemental table 2). When apathy was used as an intermediary variable, the association between depression and caregiver burden was no longer statistically significant (indirect effects; figure 2A). Apathy, anxiety and caregiver burden were also pairwise correlated (p<0.05) through simple linear regression (online supplemental table 3). When apathy served as an intermediary variable, the association between anxiety and caregiver burden remained statistically significant (p<0.05) (indirect effect; figure 2B), although the regression coefficient decreased. Apathy, cognition and caregiver burden were not pairwise correlated (online supplemental table 4).

Figure 2 (A) The mediation effect of apathy between depression and caregiver burden. (B) The mediation effect of apathy between anxiety and caregiver burden. *, p<0.05; **p<0.001. β, standardised regression coefficient.

Discussion

The current study demonstrates that apathy in ALS patients constitutes a risk factor for heightened caregiver burden. Moreover, the mediating role of apathy in the associations between depression, anxiety and caregiver burden underscores its profound impact on the latter. These findings emphasise the imperative of recognising apathy in ALS patients.

Caregiver burden refers to the stressors experienced by caregivers due to providing physical and psychological care to patients, encompassing not only social and economic costs but also mental and emotional costs.46 The rapid deterioration in ALS results in a heightened caregiver burden compared with other diseases.47 High caregiver burden hurts both the prognosis of patients with ALS and the physical and mental health of their caregivers. Previous studies have primarily focused on the influence of patient depression and anxiety on caregiver burden.48 49 Apathy, the most common behavioural disorder in ALS patients,1214 may contribute to non-adherence with treatment recommendations,15 16 leading to disease deterioration and increased caregiver burden. Even after excluding the motor and cognitive confounders among patients with ALS, apathy still exerts effects on functional independence in daily living, thereby potentially increasing the physiological burden for caregivers.50 Additionally, patients with apathy are less emotionally responsive towards their caregivers, resulting in an elevated psychological burden.

Consistent with recent studies, our findings demonstrate a positive correlation between higher levels of depression, anxiety and apathy and increased caregiver burden.51 52 Notably, in our mediation model, the association between patients’ depression and caregiver burden was fully mediated by patients’ apathy. However, the relationship between patients’ anxiety and caregiver burden was only partially mediated by patients’ apathy. On the one hand, this phenomenon may be related to the neuronal circuits underlying apathy, depression and anxiety. Both apathy and depression are associated with the dysfunction in subcortical, frontal–parietal circuitries involved in autoactivation and reward processing.5356 Anxiety, on the other hand, primarily stems from dysfunction in the basolateral amygdala and anterodorsal bed nucleus of the stria terminalis.57 58 Conversely, there is a significant overlap between the manifestations of depression and apathy.59 60 In contrast, clinical manifestations of anxiety and apathy differ markedly as ALS patients with anxiety often exhibit heightened concerns regarding their physical condition and a greater need for disease care, thereby imposing an additional burden on caregivers.

To investigate the relationship between cognitive function and caregiver burden, we employed the ECAS to evaluate the cognitive function of patients in this study. Our findings revealed no significant difference in cognition between the high and low caregiver burden groups, and regression analysis indicated that patients’ cognitive function did not influence caregiver burden, which is consistent with a previous study.26 Prior research on various neurodegenerative disorders has emphasised that the behavioural and psychological symptoms of dementia, rather than cognition per se, substantially contribute to increased caregiver burden.61 62 In a comparative study where the degree of cognitive dysfunction was similar, caring for patients with Lewy body dementia was reported to be more distressing compared with caring for Alzheimer’s disease patients due to more severe behavioural and psychological symptoms observed at early stages of Lewy body dementia.63 Family members rarely complain about challenging issues solely caused by cognitive impairments (eg, memory and visuospatial impairments) during home care. Overall, our results reinforce that cognition does not significantly impact caregiver burden.

The current study has several limitations. First, discrepancies commonly arise between patients’ and caregivers’ assessments of symptoms, particularly for apathy, possibly due to caregiver burden or lack of patient insight.64 65 The Dimensional Apathy Scale (DAS) is the gold standard for evaluating apathy in neurodegenerative diseases. It is available in two versions: a self-report and a caregiver-report version.66 Using the DAS in future studies will enhance the understanding of patients’ apathy and caregiver burden. Additionally, more appropriate anxiety assessment scales exist for ALS patients, for example, the State and Trait Anxiety Inventory Form Y.67 Second, most caregivers in this study were the patients’ spouses, which partially mitigates confounding by caregiver’s age. However, it is essential to consider other factors such as occupation, income and education, which may also influence the assessment of caregiver burden. Future studies should aim to gather more comprehensive information about caregivers. Lastly, although our sample size was larger than that of previous studies, it is worth noting that our participants were recruited solely from a single research centre in central China. Conducting multicentre studies would be beneficial in minimising bias arising from variations in economic levels and cultural backgrounds.

Conclusions

In conclusion, apathy is a crucial risk factor contributing to increased caregiver burden in patients with ALS. Apathy exerts both direct and indirect effects on caregiver burden through its association with emotional disorders. Behavioural disturbances, particularly apathy, are prevalent among individuals with ALS-frontotemporal spectrum disorders. Early identification of apathy and provision of enhanced social support to caregivers hold significant benefits for the management of ALS patients and the well-being of their caregivers.

supplementary material

10.1136/bmjopen-2023-080803 online supplemental file 1

10.1136/bmjopen-2023-080803 online supplemental file 2

10.1136/bmjopen-2023-080803 online supplemental file 3

10.1136/bmjopen-2023-080803 online supplemental file 4

10.1136/bmjopen-2023-080803 online supplemental file 5

Acknowledgements

We express our sincere gratitude to all the participants who actively contributed to this study.

Data availability statement

Data are available upon reasonable request.

Review Process File
3 9 2024

Funding: This study was supported by the National Natural Science Foundation of China (Grant No. 8227052605) and the Bethune Charitable Foundation.

Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2023-080803).

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Not applicable.

Ethics approval: This study involves human participants. The study protocol was approved by the Ethics Committee of the Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (ID: TJ-IRB20201219). Participants gave informed consent to participate in the study before taking part.

Data availability free text: The raw data of this article will be available by contacting the corresponding author.

Patient and public involvement: Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.
==== Refs
References

1 Kiernan MC Vucic S Cheah BC et al Amyotrophic lateral sclerosis Lancet 2011 377 942 55 10.1016/S0140-6736(10)61156-7 21296405
2 Dharmadasa T Kiernan MC Riluzole, disease stage and survival in ALS Lancet Neurol 2018 17 385 6 10.1016/S1474-4422(18)30091-7 29525493
3 Rothstein JD Edaravone: a new drug approved for ALS Cell 2017 171 10.1016/j.cell.2017.10.011
4 Strong MJ Abrahams S Goldstein LH et al Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria Amyotroph Later Scler Frontotemporal Degener 2017 18 153 74 10.1080/21678421.2016.1267768
5 Creemers H de Morée S Veldink JH et al Factors related to caregiver strain in ALS: a longitudinal study J Neurol Neurosurg Psychiatry 2016 87 775 81 10.1136/jnnp-2015-311651 26341327
6 Chiò A Gauthier A Vignola A et al Caregiver time use in ALS Neurol (ECronicon) 2006 67 902 4 10.1212/01.wnl.0000233840.41688.df
7 Chiò A Gauthier A Calvo A et al Caregiver burden and patients' perception of being a burden in ALS Neurol (ECronicon) 2005 64 1780 2 10.1212/01.WNL.0000162034.06268.37
8 de Wit J Bakker LA van Groenestijn AC et al Caregiver burden in amyotrophic lateral sclerosis: a systematic review Palliat Med 2018 32 231 45 10.1177/0269216317709965 28671483
9 Burke T Elamin M Galvin M et al Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors J Neurol 2015 262 1526 32 10.1007/s00415-015-7746-z 25904206
10 Kutlubaev MA Caga J Xu Y et al Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes Amyotroph Later Scler Frontotemp Degener 2023 24 14 23 10.1080/21678421.2022.2053721
11 Dickson SS Husain M Are there distinct dimensions of apathy? The argument for reappraisal Cortex 2022 149 246 56 10.1016/j.cortex.2022.01.001 35181121
12 Marin RS Apathy: concept, Syndrome, Neural Mechanisms, and Treatment Semin Clin Neuropsychiatry 1996 1 304 14 10.1053/SCNP00100304 10320433
13 Lillo P Mioshi E Zoing MC et al How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Later Scler 2011 12 45 51 10.3109/17482968.2010.520718
14 Grossman AB Woolley-Levine S Bradley WG et al Detecting neurobehavioral changes in amyotrophic lateral sclerosis Amyotroph Later Scler 2007 8 56 61 10.1080/17482960601044106
15 Witgert M Salamone AR Strutt AM et al Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis Eur J Neurol 2010 17 103 10 10.1111/j.1468-1331.2009.02801.x 19874396
16 Olney RK Murphy J Forshew D et al The effects of executive and behavioral dysfunction on the course of ALS Neurol (ECronicon) 2005 65 1774 7 10.1212/01.wnl.0000188759.87240.8b
17 Caga J Hsieh S Lillo P et al The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers Front Neurol 2019 10 192 10.3389/fneur.2019.00192 30915018
18 Wei Q-Q Guo Y Li S et al Prevalence and associated factors of apathy in Chinese ALS patients Front Psychol 2023 14 1089856 10.3389/fpsyg.2023.1089856 37063533
19 Teng EL Chui HC The Modified Mini-Mental State (3MS) examination J Clin Psychiatry 1987 48 314 8 3611032
20 Nasreddine ZS Phillips NA Bédirian V et al The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 2005 53 695 9 10.1111/j.1532-5415.2005.53221.x 15817019
21 Kacem I Abida Y Ferchichi W et al Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR) Rev Neurol (Paris) 2022 178 817 25 10.1016/j.neurol.2021.12.015 35570063
22 Lee J Kim A Choi S-J et al Development and Validation of the Korean Version of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-K) J Clin Neurol 2023 19 454 9 10.3988/jcn.2022.0403
23 Ye S Ji Y Li C et al The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population PLoS ONE 2016 11 e0155496 10.1371/journal.pone.0155496 27195772
24 Mojtabavi H Nafissi S Mahmoodi-Bakhtiari B et al Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS) Amyotroph Later Scler Frontotemp Degener 2021 22 426 33 10.1080/21678421.2021.1883665
25 Poletti B Solca F Carelli L et al The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) Amyotroph Later Scler Frontotemp Degener 2016 17 489 98 10.1080/21678421.2016.1183679
26 Caga J Hsieh S Highton-Williamson E et al The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis Amyotroph Later Scler Frontotemporal Degener 2018 19 599 605 10.1080/21678421.2018.1497659
27 Brooks BR Miller RG Swash M et al El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis Amyotroph Later Scler Other Motor Neuron Disord 2000 1 293 9 10.1080/146608200300079536
28 Rothman AA Wagner EH Chronic illness management: what is the role of primary care? Ann Intern Med 2003 138 256 61 10.7326/0003-4819-138-3-200302040-00034 12558376
29 Martínez-Martín P Forjaz MJ Frades-Payo B et al Caregiver burden in Parkinson’s disease Mov Disord 2007 22 924 31 10.1002/mds.21355 17238193
30 Pavlou M Ambler G Seaman S et al Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events Stat Med 2016 35 1159 77 10.1002/sim.6782 26514699
31 Cedarbaum JM Stambler N Malta E et al The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci 1999 169 13 21 10.1016/s0022-510x(99)00210-5 10540002
32 Roche JC Rojas-Garcia R Scott KM et al A proposed staging system for amyotrophic lateral sclerosis Brain (Bacau) 2012 135 847 52 10.1093/brain/awr351
33 Abrahams S Newton J Niven E et al Screening for cognition and behaviour changes in ALS Amyotroph Later Scler and Frontotemp Degener 2014 15 9 14 10.3109/21678421.2013.805784
34 Steer RA Clark DA Beck AT et al Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA Behav Res Ther 1999 37 183 90 10.1016/s0005-7967(98)00087-4 9990749
35 Boyd RC Le HN Somberg R Review of screening instruments for postpartum depression Arch Womens Ment Health 2005 8 141 53 10.1007/s00737-005-0096-6 16133785
36 Wang YP Gorenstein C Psychometric properties of the Beck Depression Inventory-II: a comprehensive review Braz J Psychiatry 2013 35 416 31 10.1590/1516-4446-2012-1048 24402217
37 Spitzer RL Kroenke K Williams JBW et al A brief measure for assessing generalized anxiety disorder: the GAD-7 Arch Intern Med 2006 166 1092 7 10.1001/archinte.166.10.1092 16717171
38 Johnson SU Ulvenes PG Øktedalen T et al Psychometric Properties of the General Anxiety Disorder 7-Item (GAD-7) Scale in a Heterogeneous Psychiatric Sample Front Psychol 2019 10 1713 10.3389/fpsyg.2019.01713 31447721
39 Löwe B Decker O Müller S et al Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population Med Care 2008 46 266 74 10.1097/MLR.0b013e318160d093 18388841
40 Marin RS Biedrzycki RC Firinciogullari S Reliability and validity of the Apathy Evaluation Scale Psychiatry Res 1991 38 143 62 10.1016/0165-1781(91)90040-v 1754629
41 Guimarães HC Fialho PPA Carvalho VA et al Brazilian caregiver version of the Apathy Scale Dem Neuropsychol 2009 3 321 6 10.1590/S1980-57642009DN30400010
42 Starkstein SE Mayberg HS Preziosi TJ et al Reliability, validity, and clinical correlates of apathy in Parkinson’s disease J Neuropsychiatry Clin Neurosci 1992 4 134 9 10.1176/jnp.4.2.134 1627973
43 Zarit SH Reever KE Bach-Peterson J Relatives of the impaired elderly: correlates of feelings of burden Gerontol 1980 20 649 55 10.1093/geront/20.6.649
44 Majerovitz SD Role of family adaptability in the psychological adjustment of spouse caregivers to patients with dementia Psychol Aging 1995 10 447 57 10.1037//0882-7974.10.3.447 8527065
45 Schreiner AS Morimoto T Arai Y et al Assessing family caregiver’s mental health using a statistically derived cut-off score for the Zarit Burden Interview Aging Ment Health 2006 10 107 11 10.1080/13607860500312142 16517485
46 Zarit SH Femia EE Kim K et al The structure of risk factors and outcomes for family caregivers: implications for assessment and treatment Aging Ment Health 2010 14 220 31 10.1080/13607860903167861 20336554
47 Tramonti F Bonfiglio L Bongioanni P et al Caregiver burden and family functioning in different neurological diseases Psychol Health Med 2019 24 27 34 10.1080/13548506.2018.1510131 30141703
48 Gauthier A Vignola A Calvo A et al A longitudinal study on quality of life and depression in ALS patient–caregiver couples Neurol (ECronicon) 2007 68 923 6 10.1212/01.wnl.0000257093.53430.a8
49 Tang S Li L Xue H et al Caregiver burden and associated factors among primary caregivers of patients with ALS in home care: a cross-sectional survey study BMJ Open 2021 11 e050185 10.1136/bmjopen-2021-050185
50 Aiello EN Solca F Torre S et al Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients Neurol Sci 2024 45 1087 95 10.1007/s10072-023-07074-3 37773576
51 Burke T Hardiman O Pinto-Grau M et al Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads J Neurol 2018 265 793 808 10.1007/s00415-018-8770-6 29396678
52 Chiò A Vignola A Mastro E et al Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life Eur J Neurol 2010 17 1298 303 10.1111/j.1468-1331.2010.03016.x 20402747
53 Poletti B Solca F Maffi S et al Semiology and determinants of apathy across neurodegenerative motor disorders: a comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease Front Aging Neurosci 2022 14 1031908 10.3389/fnagi.2022.1031908 36408105
54 Naismith SL Lagopoulos J Ward PB et al Fronto-striatal correlates of impaired implicit sequence learning in major depression: an fMRI study J Affect Disord 2010 125 256 61 10.1016/j.jad.2010.02.114 20219248
55 Sambuco N Bradley MM Lang PJ Trauma-related dysfunction in the fronto-striatal reward circuit J Affect Disord 2021 287 359 66 10.1016/j.jad.2021.03.043 33827011
56 Raimo S Santangelo G D’Iorio A et al Neural correlates of apathy in patients with neurodegenerative disorders: an activation likelihood estimation (ALE) meta-analysis Brain Imaging Behav 2019 13 1815 34 10.1007/s11682-018-9959-0 30238208
57 Carey G Görmezoğlu M de Jong JJA et al Neuroimaging of Anxiety in Parkinson’s Disease: a Systematic Review Mov Disord 2021 36 327 39 10.1002/mds.28404 33289195
58 Tovote P Fadok JP Lüthi A Neuronal circuits for fear and anxiety Nat Rev Neurosci 2015 16 317 31 10.1038/nrn3945 25991441
59 Tagariello P Girardi P Amore M Depression and apathy in dementia: same syndrome or different constructs? A critical review Arch Gerontol Geriatr 2009 49 246 9 10.1016/j.archger.2008.09.002 19022508
60 Starkstein SE Ingram L Garau ML et al On the overlap between apathy and depression in dementia J Neurol Neurosurg Psychiatry 2005 76 1070 4 10.1136/jnnp.2004.052795 16024880
61 Schwertner E Pereira JB Xu H et al Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: a Large-Scale Study of 10,000 Individuals J Alzheimers Dis 2022 87 1307 18 10.3233/JAD-215198 35491774
62 Kim B Noh GO Kim K Behavioural and psychological symptoms of dementia in patients with Alzheimer’s disease and family caregiver burden: a path analysis BMC Geriatr 2021 21 160 10.1186/s12877-021-02109-w 33663416
63 Yuuki S Hashimoto M Koyama A et al Comparison of caregiver burden between dementia with Lewy bodies and Alzheimer’s disease Psychogeriatrics 2023 23 682 9 10.1111/psyg.12978 37271219
64 Klar VS Ang Y-S Lockwood P et al Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version J Neuropsychol 2022 16 236 58 10.1111/jnp.12262 34532963
65 Seltzer B Vasterling JJ Mathias CW et al Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study Neuropsychiatry Neuropsychol Behav Neurol 2001 14 122 9 11417666
66 Radakovic R Stephenson L Colville S et al Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale J Neurol Neurosurg Psychiatry 2016 87 663 9 10.1136/jnnp-2015-310772 26203157
67 Siciliano M Trojano L Trojsi F et al Assessing anxiety and its correlates in amyotrophic lateral sclerosis: the state-trait anxiety inventory Muscle Nerve 2019 60 47 55 10.1002/mus.26475 30897219
